During the past decade, Charleston Area Medical Center conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 27 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 16 clinical trials were completed. i.e. 177.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Charleston Area Medical Center" #1 sponsor was "CAMC Health System" with 13 trials, followed by "Boston Scientific Corporation" with 7 trials sponsored, "Abbott Medical Devices" with 3 trials sponsored, "Cordgenics, LLC" with 3 trials sponsored and "NSABP Foundation Inc" with 3 trials sponsored. Other sponsors include 39 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Charleston Area Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "BTG International Inc." with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Charleston Area Medical Center" are "Coronary Artery Disease" (8 trials), "Cardiovascular Diseases" (4 trials), "Atherosclerosis" (3 trials), "Breast Cancer" (3 trials) and "Heart Failure" (3 trials). Many other conditions were trialed in "Charleston Area Medical Center" in a lesser frequency.

Most popular intervention types in "Charleston Area Medical Center" are "Device" (36 trials), "Drug" (28 trials), "Procedure" (6 trials), "Other" (4 trials) and "Diagnostic Test" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "ChemoID assay" (2 trials), "Chemotherapy" (2 trials), "Sham Procedure" (2 trials) and "Symplicity Spyral™ multi-electrode renal denervation system" (2 trials). Other intervention names were less common.

The vast majority of trials in "Charleston Area Medical Center" are 63 trials for "All" genders, 8 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Charleston Area Medical Center". undefined are not yet recruiting, 6 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Charleston Area Medical Center, 1 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Charleston Area Medical Center, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 25 trials that are defined as “Not Applicable".

Charleston Area Medical Center has several departments that took part in Clinical trials: "CAMC - Women and Children's Hospital" - 4 trials, "Vascular Center of Excellence" - 4 trials, "Urology center of charleston" - 3 trials, "David Lee Cancer Center at Charleston Area Medical Center" - 2 trials